Download video

2022 IME Dr. Jeffrey S. Weber, MD, PhD invites you to the 18th Annual IME Conference on Melanoma

89 views

Physicians' Education Resource

2 years ago

2022 IME Dr. Jeffrey S. Weber, MD, PhD invites you to the 18th Annual IME Conference on Melanoma

2022 IME Dr. Jeffrey S. Weber, MD, PhD invites you to the 18th Annual IME Conference on Melanoma

2022 IME Dr. Jeffrey S. Weber, MD, PhD invites you to the 18th Annual IME Conference on Melanoma
0:42
2022 IME Dr. Jeffrey S. Weber, MD, PhD invites you to the 18th Annual IME Conference on Melanoma
by Physicians' Education Resource
2022 IME Dr. Omid Hamid, MD shares the hot topics of this year's PER® IME Melanoma Conference
1:33
2022 IME Dr. Omid Hamid, MD shares the hot topics of this year's PER® IME Melanoma Conference
by Physicians' Education Resource
Join Dr. Omid Hamid and Dr. Jeffrey S. Weber at the 17th Annual International Symposium on Melanoma
5:52
Join Dr. Omid Hamid and Dr. Jeffrey S. Weber at the 17th Annual International Symposium on Melanoma
by Physicians' Education Resource
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
3:40
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
by European Society for Medical Oncology (ESMO)
Society for Melanoma Research 2022: Adjuvant and TIL Therapy
7:31
Society for Melanoma Research 2022: Adjuvant and TIL Therapy
by Medscape
Dr. Weber on Emerging Therapies in Melanoma
0:49
Dr. Weber on Emerging Therapies in Melanoma
by OncLive
Dr. Weber on FDA Approval of Pembrolizumab for Stage III Melanoma
0:57
Dr. Weber on FDA Approval of Pembrolizumab for Stage III Melanoma
by OncLive
Clinical trials investigating the treatment of melanoma
1:13
Clinical trials investigating the treatment of melanoma
by VJOncology
Dr. Weber on Risk and Benefits With Immunotherapy Combos in Melanoma
1:03
Dr. Weber on Risk and Benefits With Immunotherapy Combos in Melanoma
by OncLive
Jeffrey Weber, MD, PhD explains the importance of testing for NRAS as compared with a BRAF Biomarker
1:46
Jeffrey Weber, MD, PhD explains the importance of testing for NRAS as compared with a BRAF Biomarker
by OBRoncology
Novel biomarkers of response to ICI in melanoma
1:25
Novel biomarkers of response to ICI in melanoma
by VJOncology
Dr. Jeffrey Weber on Optimal Therapy Sequences in Advanced Melanoma
1:44
Dr. Jeffrey Weber on Optimal Therapy Sequences in Advanced Melanoma
by OncLive
Dr. Rogerio C. Lilenbaum Invites You to The 19th Annual Winter Lung Cancer Conference®
1:04
Dr. Rogerio C. Lilenbaum Invites You to The 19th Annual Winter Lung Cancer Conference®
by Physicians' Education Resource
Jeffrey Weber, MD, PhD: Factors to Consider When Determining Treatment
2:19
Jeffrey Weber, MD, PhD: Factors to Consider When Determining Treatment
by Targeted Oncology
Jeffrey Glick, MD
0:35
Jeffrey Glick, MD
by ValleyInternalMed
Dr. Jeffrey Weber Explores Nivolumab in Advanced Melanoma
2:05
Dr. Jeffrey Weber Explores Nivolumab in Advanced Melanoma
by OncLive
Immunotherapy for Melanoma
21:44
Immunotherapy for Melanoma
by AIMatMelanoma
Dr. Weber Discusses Advancements in Melanoma
1:14
Dr. Weber Discusses Advancements in Melanoma
by OncLive
Dr. Jeffrey Weber on Potential Breakthrough \\
1:21
Dr. Jeffrey Weber on Potential Breakthrough \\"Cures\\" in Melanoma
by Targeted Oncology
Dr. Weber on Testing Patients with Melanoma for Gene Mutations
1:39
Dr. Weber on Testing Patients with Melanoma for Gene Mutations
by Targeted Oncology